The immune system, in the view of many scientists, is the body’s principal defense against cancer. It acts in response to antigens present on the surfaces of cancer cells but not on normal cells and destroys the aberrant cells before they can proliferate. Cancer results when a defective immune system fails to perform adequately. If this theory is correct (and possibly even if it isn’t), augmenting the body’s capacity to mount an immune attack should be a workable strategy for preventing, controlling, or curing cancer.
KeywordsOsteogenic Sarcoma Migration Inhibitory Factor Tumor Antigen Acute Myelogenous Leukemia Transfer Factor
Unable to display preview. Download preview PDF.